Ketorolac: Difference between revisions
Ostermayer (talk | contribs) |
|||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Acute pain: | *Acute pain: | ||
**IM: | **IM: 15mg x 1 or 15mg q6h | ||
**IV: | **IV: 15mg x 1, then 15mg q6h | ||
**Black box warning against treatment for > 5 days | **Black box warning against treatment for > 5 days | ||
Revision as of 21:58, 28 November 2018
General
- Type: NSAID
- Dosage Forms: 15mg/mL, 30mg/mL injection
- Common Trade Names: Toradol
Adult Dosing
- Acute pain:
- IM: 15mg x 1 or 15mg q6h
- IV: 15mg x 1, then 15mg q6h
- Black box warning against treatment for > 5 days
Pediatric Dosing
- N/A
Special Populations
- Pregnancy Rating: C
- Lactation: Enters breast milk, use caution
- Elderly (> 65 yo): Decrease dose by 50%
- Renal Dosing
- Mild-Moderate impairment: Decrease dose by 50%
- Severe impairment or HD: Contraindicated
- Hepatic Dosing: No dose change, but may increase LFTs
Contraindications
- Allergy to class/drug
- Active or prior PUD, recent GI bleed
- Severe renal disease or HD
- Bleeding diathesis
Adverse Reactions
Serious
- Bleeding, MI, CVA, GI bleed/perforation, Hyperkalemia
Common
- Dispepsia, nausea, headache
Pharmacology
- Onset: 20-30 minutes
- Peak: 2-3 hours
- Duration: 4-6 hours
- Half-life: 2-6 hours, up to 19 hours in renal disease
- Metabolism: Hepatic
- Excretion: Renal
- Mechanism of Action: NSAID, Reversible COX-1/2 inhibitor
See Also
References
Lexicomp
